Primary leptomeningeal plasmablastic lymphoma by Mathews, Marlon S. et al.
CASE REPORT
Primary leptomeningeal plasmablastic lymphoma
Marlon S. Mathews • Daniela A. Bota •
Ronald C. Kim • Anton N. Hasso • Mark E. Linskey
Received: 7 April 2010/Accepted: 18 February 2011/Published online: 27 February 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract Lymphomas that develop in human immuno-
deﬁciency virus (HIV) infected patients are predominantly
aggressive B-cells lymphomas. The most common HIV-
associated lymphomas include Burkitt lymphoma, diffuse
large B-cell lymphoma (that often involves the CNS),
primary effusion lymphoma, and plasmablastic lymphoma
(PBL). Of these, PBL is relatively uncommon and displays
a distinct afﬁnity for presentation in the oral cavity. In this
manuscript we report a previously undescribed primary
leptomeningeal form of PBL in a patient with acquired
immunodeﬁciency syndrome. A 40-year-old HIV positive
man presented with acute onset confusion, emesis, and
altered mental status. Lumbar puncture showed numerous
nucleated cells with atypical plasmocyte predominance.
CSF ﬂowcytometry showed kappa restriction with CD8
and CD38 positivity and negative lymphocyte markers,
while the MRI showed diffuse leptomeningeal enhance-
ment. As the extensive systemic work-up failed to reveal
any disease outside the brain, an en bloc diagnostic brain
and meningeal biopsy was performed. The biopsy speci-
men showed sheets of plasmacytoid cells with one or more
large nuclei, prominent nuclear chromatin, scattered
mitoses, and abundant cytoplasm, highly suggestive of
plasmablastic lymphoma. HIV-associated malignancies
have protean and often confusing presentations, which pose
diagnostic difﬁculties posed to the practicing neurological-
surgeons. Even in cases where an infectious cause is sus-
pected for the meningeal enhancement, neoplastic
involvement should be considered, and cytology and ﬂow-
cytometry should be routinely ordered on the CSF samples.
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Clinical presentation
A 40-year-old HIV positive man presented to the emer-
gency department with acute onset confusion, emesis, and
altered mental status. Further history revealed him to be
bisexual, and a cocaine user, on chronic highly active anti-
retroviral therapy (HAART) therapy. He had a history of an
outbreak of herpes zoster a week ago, cryptococcal men-
ingitis causing blindness and deafness 3 years ago, as well
as Hepatitis-C, and anal condylomas. He was on chronic
Co-trimoxazole (trimethoprim–sulfamethoxazole) therapy,
as well as acyclovir and ﬂuconazole. At presentation, his
temperature was 36.5C, BP 140/70 mm Hg, and pulse
75/min. The patient was mildly confused and showed
mild neck stiffness. Neurologically he was drowsy but
easily awakened, and did not follow two-step commands.
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Cranial nerve examination was otherwise within normal
limits. Motor exam showed normal strength and tone
across all extremities. Sensory examination was within
normal limits. His hemoglobin was 11 mg/dl, and white
cell count was 5100/mm
3. Lumbar puncture showed a
protein level of 53 mg/dl, glucose of 49 mg/dl, and 211
nucleated cells/mm
3 with atypical plasmacyte predomi-
nance. The patient was admitted and managed as an
inpatient. CSF ﬂowcytometry showed kappa restriction
with CD8 and CD38 positivity and negative lymphocyte
markers. CSF cryptococcal antigen was negative although
serum cryptococcal antigen was positive at a titre of 64,
with no anti-cryptococcal antibody. Serum RPR and CSF
VDRL were negative and CSF AFB stain and TB PCR
were also negative. The patients CD4 count was found to
be 94 and viral load 18,500. Gadolinium enhanced MRI
scan showed diffuse leptomeningeal enhancement, with
enhancing nodules along the lateral aspect of the left
cavernous sinus and left temporal pole (Fig. 1). A meta-
static work up including cheat, abdomen and pelvis CT as
well as a whole body PET scan failed to reveal an under-
lying solid tumor. An iliac crest bone marrow biopsy
showed no evidence of plasma cell neoplasia. A right
frontal craniotomy was performed for an en bloc diagnostic
brain and meningeal biopsy. Intraoperatively the arachnoid
was found to be milky and thickened. The biopsy specimen
showed sheets of plasmacytoid cells with one or more large
nuclei, prominent nuclear chromatin, scattered mitoses, and
abundant cytoplasm, with focal extension into underlying
brain parenchyma along Virchow-Robin spaces, highly
suggestive of plasmablastic lymphoma (Fig. 2). Also were
seen scattered nests of encapsulated cryptococci within the
leptomeninges and underlying brain parenchyma with no
Fig. 1 Postgadolinium axial fat
saturated T1W MR image
shows abnormal diffuse
enhancement with in the sulcii
throughout the brain indicative
of a diffuse leptomeningeal
process (a). In addition there is
focal nodular enhancement
adjacent to the left cavernous
sinus and along the left
sphenoid ridge These nodules
could represent granulomas or
neoplastic process.
Postgadolinium Coronal fat
saturated T1W MR image
obtained 18 days after images in
a shows progression of the
diffuse leptomeningeal process
with increased hydrocephalus
(b)
Fig. 2 Typical morphological features of plasmablastic lymphoma in the meningeal biopsy: sheets of plasmacytoid cells with one or more large
nuclei, prominent nuclear chromatin, scattered mitoses, and abundant cytoplasm (a hematoxylin-eosin 9 100, b hematoxylin-eosin 9 400)
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123associated inﬂammatory response. After two additional
weeks of anti-fungal therapy for Cryptococcus, intrathecal
chemotherapy was begun for his LMM with thiotepa via an
Ommaya reservoir.
Conclusions
Plasmablastic lymphoma, originally described in 1997 by
Delecluse et al. [4] is an aggressive variant of diffuse large
B-cell non-Hodgkin lymphoma seen predominantly in a
setting of AIDS and nearly always in extranodal sites.
Subsequently, other cases have been reported, mostly in a
setting of AIDS or together with iatrogenic immune sup-
pression or advanced age [1]. Sites outside the oral cavity
have been described, including the anorectal region [2],
skin [10, 12], lung [11], and breast [16]. One previous
report has described the occurrence of a primary central
nervous system (CNS) PBL in an AIDS patient as a well-
deﬁned, hyperdense, contrast enhancing mass in the right
basal ganglia with extensive peritumoral edema and mass
effect [13]. Our report is the ﬁrst to describe the previously
unrecognized primary leptomeningeal form of PBL in an
AIDS patient. Interestingly this was associated with CNS
cyptococcosis suggesting a role for chronic antigen stim-
ulation in its pathogenesis. Such association of NHLs with
chronic infection including viral infections (EBV, HHV8)
as well as chronic tuberculous pyothorax is known to occur
[9].
Lymphomas in HIV patients are heterogenous and
reﬂect several pathogenetic mechanisms such as chronic
antigen stimulation, multiple genetic alterations, and
cytokine dysregulation. Based on a similar morphology and
behavior, plasmablastic lymphoma needs to be distin-
guished from the immunoblastic variant of diffuse large
B-cell lymphoma, classic (body cavity-based) and solid
(extracavitary) variants of primary effusion lymphoma,
Burkitt lymphoma with plasmacytoid differentiation, and
extramedullary plasmablastic tumors secondary to multiple
myeloma or plasmacytomas. Plasmablastic lymphoma is
characterized by immunoblastic morphology and plasma
cell phenotype. In other words, plasmablasts are lymphoid
cells that morphologically resemble B-cell immuno-
blasts but have acquired a plasma cell immunophenotype
(i.e, loss of B-cell markers and surface immunoglobulin
with the acquisition of plasma cell surface markers) [13].
Thus, unlike immunoblasts, plasmablasts fail to express
CD45 (leukocyte common antigen) as well as the B-cell
marker CD20 and are only variably immunoreactive for
CD79a–a broader-spectrum B-cell marker. They are also
negative for pan-T-cell markers. Positive staining for
plasma cell markers such as VS38c, CD38, MUM-1, and
CD138 indicates a phenotype akin to plasma cells [13].
PBL has been etiologically linked to Epstein-Barr virus,
Kaposi Sarcoma human virus, and human herpesvirus type-
8 infections in addition to HIV [3, 5]. Microscopic exam-
ination shows inﬁltrates of large atypical plasmacytoid
cells with abundant cytoplasm, round nuclei, and occa-
sional, centrally located, prominent nucleoli [14]. Several
different immunohistochemical markers have been used in
an attempt to characterize these lesions [6]. Of these CD
138 is most consistently positive and indicates plasma cell
differentiation of the tumor cells [6, 8]. Immunoglobin
heavy and light chain restrictions are often present [2, 15].
Ultrastructural features under electron microcopy include
round nuclei with clumped heterochromatin and large
nucleoli, with concentrically arranged rough endoplasmic
reticulum in the cytoplasm [7].
HIV associated PBL has been treated with a variety of
chemotherapeutic agents, but the efﬁcacy of treatment is
unclear. The previously reported case of CNS PBL was
treated with intrathecal methotrexate but the patient was
lost to follow up and the outcome is uncertain [15].
Published reports indicate that these are aggressive
tumors, frequently resistant to therapy, and often rapidly
fatal.
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